This discordance may be explained by the significant tumor burden (Metabolic Tumor Volume26 >240; beta 2 microglobulin= 9) in this second patient, and points to the presence of a residual reservoir of tumor cells with retained TNFRSF17. The gene discussed is B2M; the disease is neoplasm.